Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that it will host a conference call and live webcast to discuss the Company’s first quarter 2024 financial results and provide a business update at 8:30 a.m. ET on Tuesday, May 14, 2024. Ocugen will issue a pre-market e...
10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series Ahead Of Cinco De Mayo, 10 Barrel’s Award-Winning Brew Team Introduces Pub Cerveza, A Traditional Mexican Style Lager BEND, Ore., May 03, 2024 (GLOBE NEWSWIRE) -- ("10 Barrel Brewing Co." or "10 Barrel"), a Pacific Northwestern pioneer in craft brewing, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), unveils its latest creation: Pub Cerveza. Building upon the legacy of the ‘Cheap Fun.’ family, which includes and , Pub Cerveza brings south-of-the-border spirit to the party in a smooth, crusha...
SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Viad Corp (NYSE: VVI), a leading global provider of extraordinary experiences, including attractions, hospitality, exhibition management services, and experiential marketing, today reported results for the 2024 first quarter. Steve Moster, Viad’s President and Chief Executive Officer, commented, “We delivered solid first quarter results that were in line with our expectations. Pursuit's 14% revenue growth during the seasonally slower quarter was driven by strong attractions performance, including an impressive launch of our new FlyOver Chicago attraction....
Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress MALVERN, Pa., May 02, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Arun Upadhyay, PhD, Chief Scientific Officer, Head of Research & Development, Ocugen will speak at the Retina World Congress (RWC) being held May 9-12, 2024 in Ft. Lauderdale, FL. “This is a terrific opportunity to share the most recent developments in modifier gene ...
Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage XMG Cannabis Brand Releases Latest Innovations with XMG Zero and XMG+ Beverages Now Available Across Canada TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced a bold new range of cannabis-infused beverages from , under two of its sub-brands: XMG Zero and XMG Plus (“XMG+”). XMG Zero, an extension of XMG’s original core line, now offers two new THC beverages: Cream Soda Zero and Orange Soda ...
Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen New Variety 12-pack Features Hefe, Widberry Hefe, Apricot Hefe and Imperial Hefe PORTLAND, Ore., May 01, 2024 (GLOBE NEWSWIRE) -- (“”), brewers of The Original American Hefeweizen, and a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY and TSX: TLRY), is launching a new Hefe Variety 12 Pack, showcasing a wide range of delicious wheat beer style brews. As creators of the American Wheat Beer style, Widmer Brothers has always been a leader in showcasing how wheat ...
Great Lakes Dredge & Dock Corporation Schedules Announcement of 2024 First Quarter Results HOUSTON, April 30, 2024 (GLOBE NEWSWIRE) -- Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) today announced that it will release the financial results for its three months ended March 31, 2024 on Tuesday, May 7, 2024 at 7:00 a.m. C.D.T. A conference call with the Company will be held the same day at 9:00 a.m. C.D.T. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate ac...
Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner’ The Perfect Beer for Toasting The Trail Less Traveled LITTLETON, Colo., April 29, 2024 (GLOBE NEWSWIRE) -- a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to introduce a new West Coast style IPA – 'Ridge Runner' – to its portfolio of well balanced and drinkable craft beers. Ridge Runner is inspired by the untamed beauty of Colorado’s trails and, like all Breck Brew beers, is the perfect accessory to an active Colorado lifestyle—whether on top of the summit or after a long day exploring...
Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024 MALVERN, Pa., April 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that Benjamin Bakall, MD, PhD, Director of Clinical Research at Associated Retina Consultants and Clinical Assistant Professor at the University of Arizona, College of Medicine—Phoenix will present data from the OCU400 Phas...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Moody's Ratings (Moody's) affirmed Great Lakes Dredge & Dock Corporation's ("Great Lakes") B2 Corporate Family Rating (CFR), its B2-PD probability of default rating ("PDR"). The rating on the company's senior unsecured notes was downgraded to Caa1 from B3. The speculative grade liquidity ("SGL") rat...
UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa (Phase 3 LiMeliGhT clinical trial), OCU410 for the treatment of geographic ...
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa (Phase 3 LiMeliGhT clinical trial), OCU410 for the treatment of geographic atrophy (P...
Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World 10 Barrel Brewing Wins Innovation in Craft Brewing Award and Sweeps German-Style Sour Ale Category with Gold, Silver, and Bronze Medals Green Flash Brewing Wins Bronze in Juicy or Hazy Pale Ale Category NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq | TSX: TLRY), a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the . 10 Barrel Brewing won four craft beer awards and 10 Bar...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings (NYSE: UVE) (“Universal” or the “Company”) reported first quarter 2024 results. “It was a strong quarter, including a 29.4% annualized adjusted return on common equity and 35.4% adjusted diluted EPS growth year-over-year,” said Stephen J. Donaghy, Chief Executive Officer. “Results were solid across the board, including profitable underwriting that was complemented by our non-underwriting operations, which is a testament to our differentiated business model. Direct premiums written growth accelerated sequentially, as polici...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.